Capital Market Strategies »

Novo Nordisk A/S shares owned by Capital Market Strategies

Quarter-by-quarter ownership of Novo Nordisk A/S (NVO) shares owned by Capital Market Strategies from 13F filings

Historical chart of Capital Market Strategies investment in Novo Nordisk A/S

Tip: Access up to 7 years of quarterly data

All positions including Novo Nordisk A/S held by Capital Market Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Novo Nordisk A/S by Capital Market Strategies

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.3M 9.8k 128.40
2023-12-31 $948k 9.2k 103.45
2023-09-30 $703k 8.0k 87.78
2023-06-30 $541k 3.3k 161.83
2022-12-31 $261k 1.9k 135.34

More positions owned by Capital Market Strategies

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
First Bank (FRBA)
Ishares Tr Fltg Rate Nt Etf (FLOT)
Invesco Exchange Traded Fd T Ftse Rafi 1000 (PRF)
Invesco Exchange Traded Fd T S&p500 Eql Tec (RSPT)
Ishares Tr Core S&p Ttl Stk (ITOT)
Eli Lilly & Co. (LLY)
Home Depot (HD)
Etf Opportunities Trust Applied Fina Val (VSLU)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Abbvie (ABBV)
Costco Wholesale Corporation (COST)
Schwab Strategic Tr Us Dividend Eq (SCHD)

View all positions for Capital Market Strategies

Top funds holding Novo Nordisk A/S

Jennison Associates
Fisher Investments
Bank of America Corporation
Fayez Sarofim & Co
Folketrygdfondet
Polen Capital Management
T. Rowe Price Associates
Everett Harris & Co
State Farm Mutual Automobile Insurance Company
Goldman Sachs Group
Jpmorgan Chase & Co
WCM Investment Management
Sustainable Growth Advisers
Wells Fargo & Company
Royal Bank of Canada

View all funds holding Novo Nordisk A/S